Outcomes of Autologous Bone Marrow Mononuclear Cell Administration in the Treatment of Neurologic Sequelea in Children With Spina Bifida

NCT05472428 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Stem Cell Infusion

Interventions

COMBINATION_PRODUCT: Autologous bone marrow mononuclear cell transplantation

Sponsor

Vinmec Research Institute of Stem Cell and Gene Technology

Collaborators

[object Object]